Buscar
Mostrando ítems 61-70 de 2348
Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype
(Springer, 2021-06)
Introduction: Non-invasive biomarkers are needed for metabolic dysfunction-associated fatty liver disease (MAFLD), especially for patients at risk of disease progression in high-prevalence areas. The microbiota and its ...
Intersection between metabolic dysfunction, high fat diet consumption, and brain aging
(Wiley Blackwell Publishing, Inc, 2010-07)
Deleterious neurochemical, structural, and behavioral alterations are a seemingly unavoidable aspect of brain aging. However, the basis for these alterations, as well as the basis for the tremendous variability in regards ...
Bifidobacterium CECT 7765 improves metabolic and immunological dysfunction associated with obesity in high-fat diet fed mice
(John Wiley & Sons Inc, 2013-11)
Objectives: To evaluate the effects of administration of Bifidobacterium pseudocatenulatum CECT 7765 on metabolic and immune alterations in obese mice.
Design and Methods: Adult male wild-type C57BL-6 mice were fed a ...
Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome
(Elsevier Ireland LtdClareIrlanda, 2007)
In vivo vascular rarefaction and hypertension induced by dexamethasone are related to phosphatase PTP1B activation not endothelial metabolic changes
(2020-05-20)
Glucocorticoids have important anti-inflammatory and immunomodulatory activities. Dexamethasone (Dex), a synthetic glucocorticoid, induces insulin resistance, hyperglycemia, and hypertension. The hypertensive mechanisms ...
Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity
(Taylor & Francis, 2021)
Chronic Metabolic Derangement-Induced Cognitive Deficits and Neurotoxicity Are Associated with REST Inactivation
(2019-03-01)
Chronic metabolic alterations may represent a risk factor for the development of cognitive impairment, dementia, or neurodegenerative diseases. Hyperglycemia and obesity are known to imprint epigenetic markers that compromise ...
Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome
(ACADEMIC PRESS INC ELSEVIER SCIENCE,, 2012)